SCHEMBL24865191

SCHEMBL24865191

CN1C(=O)CCOc2cc(Nc3ccc(N4CCC(C(F)(F)F)CC4)cc3)ccc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.36
TRPV1 Q8NER1 5/20 0.36
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
HTR1A P08908 2/20 0.35
HTR2C P28335 2/20 0.35
BRD4 O60885 2/20 0.35
KRAS P01116 1/20 0.34
SOS1 Q07889 1/20 0.34
BCL6 P41182 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
DCLK1 O15075 1/20 0.33
LRRK2 Q5S007 1/20 0.33
DYRK3 O43781 1/20 0.33
CLK1 P49759 1/20 0.33
CLK2 P49760 1/20 0.33
CLK3 P49761 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24865342 0.90 GABRG2 (0.44) CNR2TRPV1GABRG2GABRB3GABRA5
SCHEMBL31123189 0.90 GABRG2 (0.44) CNR2TRPV1GABRG2GABRB3GABRA5
SCHEMBL24864870 0.89 DCLK1 (0.36) TRPV1GABRG2GABRB3GABRA5HTR1A
SCHEMBL24865433 0.85 ALDH1A1 (0.42) CNR2BRD4MAPT
SCHEMBL24865338 0.84 TRIM24 (0.42) CNR2TRPV1GABRG2GABRB3GABRA5
SCHEMBL31123354 0.83 HTR1A (0.43) TRPV1GABRG2GABRB3GABRA5HTR1A
SCHEMBL24865628 0.83 HTR1A (0.43) TRPV1GABRG2GABRB3GABRA5HTR1A
SCHEMBL24864950 0.82 GABRG2 (0.44) CNR2TRPV1GABRG2GABRB3GABRA5
SCHEMBL24865288 0.80 HTR1A (0.43) TRPV1GABRG2GABRB3GABRA5HTR1A
SCHEMBL30336564 0.80 HTR1A (0.43) TRPV1GABRG2GABRB3GABRA5HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 CNR2 3115/4885TRPV1 3135/4885GABRG2 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.